What is Evvy?
Evvy operates at the intersection of biotechnology and consumer wellness, providing a comprehensive at-home testing platform specifically designed for women. By leveraging advanced microbiome sequencing and personalized health insights, the company addresses critical gaps in traditional healthcare, where vaginal health issues have historically been underserved or misdiagnosed. The firm's market position is defined by its commitment to empowering users with actionable data, effectively bridging the gap between clinical diagnostics and daily wellness management. As a category-defining entity, Evvy utilizes its proprietary technology to transform how individuals monitor their health, positioning itself as a vital player in the broader digital health ecosystem.
How much funding has Evvy raised?
Evvy has raised a total of $19M across 2 funding rounds:
Angel/Seed
$5M
Series A
$14M
Angel/Seed (2021): $5M with participation from Box Group, General Catalyst, BBG Ventures, Human Ventures, Virtue, and G9 Ventures
Series A (2023): $14M led by Labcorp, Virt Investments, RH Capital, Left Lane Capital, and General Catalyst
Key Investors in Evvy
General Catalyst
A prominent venture capital firm that partners with founders to build enduring enterprises by providing deep sector expertise and operational support across multiple growth stages.
Labcorp
A global leader in laboratory services and diagnostics, providing critical health information to patients and providers through an extensive network of clinical testing facilities.
Left Lane Capital
A New York-based growth equity firm focused on investing in high-growth consumer internet and technology companies that foster lasting customer relationships.
What's next for Evvy?
With the recent influx of capital, Evvy is well-positioned to accelerate its product development roadmap and expand its diagnostic capabilities. The strategic focus will likely center on deepening its clinical research partnerships and enhancing its digital interface to provide more granular, longitudinal health tracking for its user base. By scaling its infrastructure, the company aims to solidify its leadership in the women's health market, potentially exploring new diagnostic verticals and strengthening its presence in the enterprise healthcare space. The continued support from high-profile venture firms suggests a long-term commitment to building an enduring, data-rich platform that fundamentally alters the standard of care for women's health.
See full Evvy company page
